| Title |
Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis / |
| Authors |
Liakina, Valentina ; Strainienė, Sandra ; Stundienė, Ieva ; Maksimaitytė, Vaidota ; Kazėnaitė, Edita |
| DOI |
10.4254/wjh.v14.i7.1277 |
| Full Text |
|
| Is Part of |
World journal of hepatology.. Pleasanton : Baishideng Publishing Group Inc. 2022, vol. 14, no. 7, p. 1277-1290.. ISSN 1948-5182 |
| Keywords [eng] |
gut microbiota ; hepatocellular carcinoma ; non-alcoholic steatohepatitis ; non-alcoholic fatty liver disease ; microbiome |
| Abstract [eng] |
Recently, the gut microbiota has been recognized as an obvious active player in addition to liver steatosis/steatohepatitis in the pathophysiological mechanisms of the development of hepatocellular carcinoma (HCC), even in the absence of cirrhosis. Evidence from clinical and experimental studies shows the association of specific changes in the gut microbiome and the direct contribution to maintaining liver inflammation and/or cancerogenesis in nonalcoholic fatty liver disease-induced HCC. The composition of the gut microbiota differs significantly in obese and lean individuals, especially in the abundance of pro-inflammatory lipopolysaccharide-producing phyla, and, after establishing steatohepatitis, it undergoes minor changes during the progression of the disease toward advanced fibrosis. Experimental studies proved that the microbiota of obese subjects can induce steatohepatitis in normally fed mice. On the contrary, the transplantation of healthy microbiota to obese mice relieves steatosis. However, further studies are needed to confirm these findings and the mechanisms involved. In this review, we have evaluated well-documented clinical and experimental research on the role of the gut microbiota in the manifestation and promotion of HCC in nonalcoholic steatohepatitis (NASH). Furthermore, a literature review of microbiota alterations and consequences of dysbiosis for the promotion of NASH-induced HCC was performed, and the advantages and limitations of the microbiota as an early marker of the diagnosis of HCC were discussed. |
| Published |
Pleasanton : Baishideng Publishing Group Inc |
| Type |
Journal article |
| Language |
English |
| Publication date |
2022 |
| CC license |
|
